The Recall Desk

Manufacturer

ALLERGAN

4 recalls in our database name ALLERGAN as the manufacturing or recalling firm.

What the numbers show

Total
4
Critical
0
Severe
0
Most recent
2018-12-05

Of the 4 recalls from ALLERGAN we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–4 of 4

  • ModerateFDA (Drugs)·D-0282-2019·2018-12-05

    Allergan Recalls INFed Iron Dextran Injection for Stability Failure

    Allergan is recalling INFed (Iron Dextran Injection) vials because they failed stability specifications for iron content. The product was distributed throughout the United States.

    Product
    INFed (Iron Dextran Injection USP) 100 mg elemental iron/2 mL (50 mg/mL), Rx only, packaged in 2 mL Sterile Single Dose Vial, Mfd by Patheon Italia S.p.A. Ferentino, Italy NDC 52544-931-07
    Category
    Drug
    Distribution
    0 states
  • ModerateFDA (Drugs)·D-0545-2018·2018-03-07

    Allergan Recalls Iron Dextran Injection Due to Stability Failures

    Allergan is recalling INFeD (Iron Dextran Injection USP) because stability testing showed the product did not meet specifications for iron content.

    Product
    INFeD (Iron Dextran Injection USP) 100 mg elemental iron/2 ml (50 mg/mL), Rx Only, packaged in a) single dose vials, (NDC 52544-931-07), b) carton of 10 x 2 ml Single Dose Vials (NDC 52544-931-02) Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054, Manufactured by: Patheon
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0413-2018·2018-02-21

    Allergan Recalls NORCO Tablets Due to Missing Controlled Substance Labeling

    Allergan is recalling 8 bottles of NORCO tablets because the primary label is missing the required CII controlled drug classification indication.

    Product
    NORCO (Hydrocodone Bitartrate and Acetaminophen) Tablets, USP, 10 mg/325 mg, 100-count bottles, Rx Only, Distributed by: Allergan USA, Inc., Irvine, CA 92612, NDC 0023-6022-01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0154-2018·2018-01-17

    Allergan Recalls One Lot of Viokace Tablets Due to Stability Testing Failures

    Allergan is recalling one lot of Viokace tablets because stability testing results did not meet specifications for enzyme profile.

    Product
    Viokace (pancrelipase) tablets, 20,880 USP units, 100-count bottle, Rx only, Distributed by; Allergan USA Inc., Irvine, CA 92612, Manufactured in Canada, NDC 58914-117-10
    Category
    Drug
    Distribution
    Distributed nationwide

About this company

Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.

Allergan, Inc.

U.S. subsidary of Allergan plc

Country
United States
Founded
1950
Parent company
Allergan plc

Official website

Source: Wikidata (Q505866), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.